Preferred Label : buspirone;
MeSH definition : An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione
class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but
it has an efficacy comparable to DIAZEPAM.;
MeSH synonym : n-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide;
CISMeF synonym : pharmascience brand of buspirone hydrochloride; ratiopharm brand of buspirone hydrochloride; eisai brand of buspirone hydrochloride; apotex brand of buspirone hydrochloride; novopharm brand of buspirone hydrochloride; hormosan brand of buspirone hydrochloride; Bristol-Myers squibb brand of buspirone hydrochloride; bristol myers squibb brand of buspirone hydrochloride; UPSA brand of buspirone hydrochloride; Bristol-Myers brand of buspirone hydrochloride; bristol myers brand of buspirone hydrochloride; genpharm brand of buspirone; linson pharma brand of buspirone hydrochloride; armstrong brand of buspirone hydrochloride; Nu-Pharm brand of buspirone hydrochloride; nu pharm brand of buspirone hydrochloride; hexal brand of buspirone hydrochloride;
MeSH hyponym : Apo-Buspirone; ratio-Buspirone; Nu-Buspirone; busp; neurosine; Novo-Buspirone; Lin-Buspirone; anxut; Gen-Buspirone; PMS-Buspirone; MJ-9022-1; buspar; buspirone hydrochloride; Hydrochloride, Buspirone; Gen Buspirone; Lin Buspirone; MJ 9022 1; MJ90221; Nu Buspirone; PMS Buspirone; Ratio Buspirone; Apo Buspirone; Bespar; Novo Buspirone;
MeSH CAS label : 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-;
MeSH Related Number : buspirone hydrochloride; 33386-08-2 (Buspirone hydrochloride); 36505-84-7 (Buspirone); 207LT9J9OC;
Registry Number MeSH : 36505-84-7;
Related CAS MeSH : 207LT9J9OC (Buspirone hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Buspirone;
Codes EINECS : 253-072-2;
Is substance : O;
UNII : TK65WKS8HL;
InChIKey : QWCRAEMEVRGPNT-UHFFFAOYSA-N;
Origin ID : D002065;
UMLS CUI : C0006462;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione
class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but
it has an efficacy comparable to DIAZEPAM.
http://www.has-sante.fr/portail/jcms/c_2730773/fr/buspirone-mylan
2016
false
false
false
France
French
evaluation of the transparency committee
buspirone
buspirone
---
https://pharmacomedicale.org/medicaments/par-specialites/item/buspirone
2016
false
false
false
France
French
drug information
buspirone
anti-anxiety agents
buspirone
serotonin 5-HT1 receptor agonists
anxiety disorders
Generalized Anxiety Disorder
buspirone
buspirone
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65885296
2012
France
summary of product characteristics
package leaflet
buspirone
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63305905
2012
France
summary of product characteristics
package leaflet
tablets
buspirone
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61964472
2012
France
summary of product characteristics
package leaflet
buspirone
tablets
---
http://www.meddispar.fr/medicaments/3766553
2008
France
French
administration, oral
buspirone
tablets
drugs, generic
drug prescriptions
legislation, drug
buspirone
drug information
---
http://www.meddispar.fr/medicaments/3480259
2008
France
French
administration, oral
buspirone
tablets
drug prescriptions
legislation, drug
buspirone
drug information
---
http://www.lecrat.eu/?s=Buspirone
2006
France
French
pregnancy
buspirone
anti-anxiety agents
buspirone
drug information
---
http://www.has-sante.fr/portail/display.jsp?id=c_400901
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032480.pdf
2006
France
French
buspirone
administration, oral
anti-anxiety agents
buspirone
insurance, health, reimbursement
anxiety disorders
treatment outcome
tablets
evaluation of the transparency committee
---